Sponsored by:

Nuclear Medicine: Page 53

ImaginAb touts research on T-cell PET imaging agent
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb said data from the first-in-human imaging study of its CD8 T-cell PET agent for use in detecting solid malignancies were published online October 4 in the Journal of Nuclear Medicine.
October 7, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
October 7, 2019
Shine secures $50M in financing
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies has secured $50 million in financing with funds managed by Oaktree Capital Management of Los Angeles.
October 7, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
Decision in Bracco-Jubilant case under review
By AuntMinnie.com staff writers
The U.S. International Trade Commission has agreed to review a ruling by an administrative law judge that Jubilant DraxImage did not violate unfair competition with the exportation of its rubidium elution systems into the U.S., as alleged in a complaint from contrast developer Bracco Diagnostics.
October 2, 2019
2016 12 21 15 58 26 460 Scales Of Justice 400
ITM, Bruce Power complete feasibility study
By AuntMinnie.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München and Canadian isotope supplier Bruce Power have completed a joint feasibility study for the irradiation of ytterbium-176 to produce lutetium-177.
October 1, 2019
2016 10 18 11 34 57 70 Check Mark 400
Shine, Phoenix claim world record
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies and nuclear technology company Phoenix are laying claim to a new world record for a nuclear fusion reaction.
October 1, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
CMS gets pushback on PET fee cuts
By AuntMinnie.com staff writers
Imaging organizations opposing the U.S. Centers for Medicare and Medicaid Services' (CMS) proposed payment reductions related to myocardial PET equipment and services have received support from 43 members of Congress.
October 1, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
Lantheus to acquire Progenics
By AuntMinnie.com staff writers
Lantheus Holdings has signed a definitive agreement to acquire oncology firm Progenics Pharmaceuticals in an all-stock transaction.
October 1, 2019
2016 08 24 09 43 13 537 Hands Shaking V3 400
Ga-68 PSMA-11 PET interpretation criteria need work
By Wayne Forrest
Interpretation criteria for gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) PET with CT or MRI for prostate cancer can bolster interreader agreement, but some performance issues remain, according to a study published online September 27 in the Journal of Nuclear Medicine.
October 1, 2019
2019 04 17 20 48 2514 Prostate 3 D 400
Magnetic Insight wins NIH grant
By AuntMinnie.com staff writers
The U.S. National Institutes of Health (NIH) National Cancer Institute has awarded a new research grant to magnetic particle imaging (MPI) technology developer Magnetic Insight.
September 30, 2019
PET/CT beats SPECT for neuroendocrine tumors
By Wayne Forrest
PET/CT performed better than planar scintigraphy or SPECT for determining which patients with neuroendocrine tumors are most likely to benefit from peptide receptor radionuclide therapy, in a study published in the September issue of the Journal of Nuclear Medicine.
September 26, 2019
2019 09 26 17 12 9463 Krenning Scores Net Jnm Hope 20190926175008
FDA approves BWXT's radiopharmaceutical
By AuntMinnie.com staff writers
U.S. government nuclear components supplier BWX Technologies (BWXT) has received approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for a generic version of indium-111 (In-111) oxyquinoline solution.
September 25, 2019
2016 04 11 16 41 58 174 Approved Stamp 200
Previous Page
Page 53 of 440
Next Page